S. Josefowicz, L. Lu, and A. Rudensky, Regulatory T Cells: Mechanisms of Differentiation and Function, Annual Review of Immunology, vol.30, issue.1, pp.531-564, 2012.
DOI : 10.1146/annurev.immunol.25.022106.141623

N. Ohkura, M. Hamaguchi, H. Morikawa, K. Sugimura, A. Tanaka et al., T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development, Immunity, vol.37, issue.5, pp.785-799, 2012.
DOI : 10.1016/j.immuni.2012.09.010

J. Huehn, J. Polansky, and A. Hamann, Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?, Nature Reviews Immunology, vol.105, issue.2, pp.83-89, 2009.
DOI : 10.1038/nri2474

L. Francisco, P. Sage, and A. Sharpe, The PD-1 pathway in tolerance and autoimmunity, Immunological Reviews, vol.183, issue.1, pp.219-242, 2010.
DOI : 10.1111/j.1600-065X.2010.00923.x

V. Barnaba and V. Schinzari, Induction, control, and plasticity of Treg cells: The immune regulatory network revised?, European Journal of Immunology, vol.186, issue.6, pp.318-322, 2013.
DOI : 10.1002/eji.201243265

D. Franceschini, M. Paroli, V. Francavilla, M. Videtta, S. Morrone et al., PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV, Journal of Clinical Investigation, vol.119, issue.3, pp.551-564, 2009.
DOI : 10.1172/JCI36604DS1

M. Croft, Control of Immunity by the TNFR-Related Molecule OX40 (CD134), Annual Review of Immunology, vol.28, issue.1, pp.57-78, 2010.
DOI : 10.1146/annurev-immunol-030409-101243

A. Burocchi, P. Pittoni, A. Gorzanelli, M. Colombo, and S. Piconese, Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells, European Journal of Immunology, vol.170, issue.12, pp.3615-3626, 2011.
DOI : 10.1002/eji.201141700

B. Valzasina, C. Guiducci, H. Dislich, N. Killeen, A. Weinberg et al., Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR, Blood, vol.105, issue.7, pp.2845-2851, 2005.
DOI : 10.1182/blood-2004-07-2959

M. Vu, X. Xiao, W. Gao, N. Degauque, M. Chen et al., OX40 costimulation turns off Foxp3+ Tregs, Blood, vol.110, issue.7, pp.2501-2510, 2007.
DOI : 10.1182/blood-2007-01-070748

D. Hirschhorn-cymerman, G. Rizzuto, T. Merghoub, A. Cohen, F. Avogadri et al., OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis, The Journal of Experimental Medicine, vol.163, issue.5, pp.1103-1116, 2009.
DOI : 10.1084/jem.188.2.287

S. Piconese, B. Valzasina, and M. Colombo, OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection, The Journal of Experimental Medicine, vol.2, issue.4, pp.825-839, 2008.
DOI : 10.1038/nrc2250

A. Weinberg, N. Morris, M. Kovacsovics-bankowski, W. Urba, and B. Curti, Science gone translational: the OX40 agonist story, Immunological Reviews, vol.37, issue.1, pp.218-231, 2011.
DOI : 10.1111/j.1600-065X.2011.01069.x

T. Griseri, M. Asquith, C. Thompson, and F. Powrie, OX40 is required for regulatory T cell???mediated control of colitis, The Journal of Experimental Medicine, vol.163, issue.4, pp.699-709, 2010.
DOI : 10.1038/nature07674

K. Hippen, P. Harker-murray, S. Porter, S. Merkel, A. Londer et al., Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells, Blood, vol.112, issue.7, pp.2847-2857, 2008.
DOI : 10.1182/blood-2008-01-132951

S. Piconese, P. Pittoni, A. Burocchi, A. Gorzanelli, A. Care et al., A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2, European Journal of Immunology, vol.26, issue.10, pp.2902-2913, 2010.
DOI : 10.1002/eji.201040505

C. Ruby, M. Yates, D. Hirschhorn-cymerman, P. Chlebeck, J. Wolchok et al., Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right, The Journal of Immunology, vol.183, issue.8, pp.4853-4857, 2009.
DOI : 10.4049/jimmunol.0901112

M. Barnes and F. Powrie, Hybrid Treg cells: steel frames and plastic exteriors, Nature Immunology, vol.27, issue.6, pp.563-564, 2009.
DOI : 10.1038/ni0609-563

S. Bailey-bucktrout and J. Bluestone, Regulatory T cells: stability revisited, Trends in Immunology, vol.32, issue.7, pp.301-306, 2011.
DOI : 10.1016/j.it.2011.04.002

Y. Kim, R. Bhairavabhotla, J. Yoon, A. Golding, A. Thornton et al., Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion, Blood, vol.119, issue.12, pp.2810-2818, 2012.
DOI : 10.1182/blood-2011-09-377895

W. Liu, A. Putnam, Z. Xu-yu, G. Szot, M. Lee et al., T reg cells, The Journal of Experimental Medicine, vol.376, issue.7, pp.1701-1711, 2006.
DOI : 10.1016/S0092-8674(04)00127-8

N. Kobayashi, N. Hiraoka, W. Yamagami, H. Ojima, Y. Kanai et al., FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis, Clinical Cancer Research, vol.13, issue.3, pp.902-911, 2007.
DOI : 10.1158/1078-0432.CCR-06-2363

J. Fu, D. Xu, Z. Liu, M. Shi, P. Zhao et al., Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients, Gastroenterology, vol.132, issue.7, pp.2328-2339, 2007.
DOI : 10.1053/j.gastro.2007.03.102

M. Koch, K. Thomas, N. Perdue, K. Smigiel, S. Srivastava et al., T-bet+ Treg Cells Undergo Abortive Th1 Cell Differentiation due to Impaired Expression of IL-12 Receptor ??2, Immunity, vol.37, issue.3, pp.501-510, 2012.
DOI : 10.1016/j.immuni.2012.05.031

M. Koch, G. Tucker-heard, N. Perdue, J. Killebrew, K. Urdahl et al., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation, Nature Immunology, vol.446, issue.6, pp.595-602, 2009.
DOI : 10.1038/ni.1731

M. Nagar, J. Jacob-hirsch, H. Vernitsky, Y. Berkun, S. Ben-horin et al., TNF Activates a NF-??B-Regulated Cellular Program in Human CD45RA- Regulatory T Cells that Modulates Their Suppressive Function, The Journal of Immunology, vol.184, issue.7, pp.3570-3581, 2010.
DOI : 10.4049/jimmunol.0902070

M. Miyara, Y. Yoshioka, A. Kitoh, T. Shima, K. Wing et al., Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor, Immunity, vol.30, issue.6, pp.899-911, 2009.
DOI : 10.1016/j.immuni.2009.03.019

K. Schakel, M. Von-kietzell, A. Hansel, A. Ebling, L. Schulze et al., Human 6-Sulfo LacNAc-Expressing Dendritic Cells Are Principal Producers of Early Interleukin-12 and Are Controlled by Erythrocytes, Immunity, vol.24, issue.6, pp.767-777, 2006.
DOI : 10.1016/j.immuni.2006.03.020

L. Ziegler-heitbrock, P. Ancuta, S. Crowe, M. Dalod, V. Grau et al., Nomenclature of monocytes and dendritic cells in blood, Blood, vol.116, issue.16, pp.74-80, 2010.
DOI : 10.1182/blood-2010-02-258558
URL : https://hal.archives-ouvertes.fr/hal-00611173

D. Mosser and J. Edwards, Exploring the full spectrum of macrophage activation, Nature Reviews Immunology, vol.117, issue.12, pp.958-969, 2008.
DOI : 10.1038/nri2448

F. Balkwill, Tumour necrosis factor and cancer, Nature Reviews Cancer, vol.265, issue.5, pp.361-371, 2009.
DOI : 10.1038/nature01322

A. Sica and A. Mantovani, Macrophage plasticity and polarization: in vivo veritas, Journal of Clinical Investigation, vol.122, issue.3, pp.787-795, 2012.
DOI : 10.1172/JCI59643DS1

J. Zhang, X. Wu, Y. B. Wang, Y. Feng, G. Jiang et al., Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C, European Journal of Immunology, vol.51, issue.7, pp.1953-1962, 2013.
DOI : 10.1002/eji.201243097

X. Chen, M. Baumel, D. Mannel, O. Howard, and J. Oppenheim, Interaction of TNF with TNF Receptor Type 2 Promotes Expansion and Function of Mouse CD4+CD25+ T Regulatory Cells, The Journal of Immunology, vol.179, issue.1, pp.154-161, 2007.
DOI : 10.4049/jimmunol.179.1.154

C. Camisaschi, P. Filipazzi, M. Tazzari, C. Casati, V. Beretta et al., Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response, Cancer Immunology, Immunotherapy, vol.186, issue.5, pp.897-908, 2013.
DOI : 10.1007/s00262-013-1397-7

J. Shindoh, K. Hasegawa, Y. Matsuyama, Y. Inoue, T. Ishizawa et al., Low Hepatitis C Viral Load Predicts Better Long-Term Outcomes in Patients Undergoing Resection of Hepatocellular Carcinoma Irrespective of Serologic Eradication of Hepatitis C Virus, Journal of Clinical Oncology, vol.31, issue.6, pp.766-773, 2013.
DOI : 10.1200/JCO.2012.44.3234

R. Deleeuw, S. Kost, J. Kakal, and B. Nelson, The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature, Clinical Cancer Research, vol.18, issue.11, pp.3022-3029, 2012.
DOI : 10.1158/1078-0432.CCR-11-3216